Advertisement
Browse 144 market data tables and in-depth TOC on drug-device market.Early buyers will receive 10% customization of reports
http://www.marketsandmarkets.com/Market-Reports/drug-and-device-combinati
Advertisement
on-101.html
(Due to the length of this URL, it may be necessary to copy and pastethis hyperlink into your Internet browser's URL address field. Remove thespace if one exists.)
The drug-device combination market ( http://www.marketsandmarkets.com/Market-Reports/drug-and-device-combination-101.html ) includes all theproducts that are a combination of drugs and devices and can be chemically orphysically united or co-packaged as separate, cross labeled products. Themarket is driven by the growing demand for treating only the ; targeted area,increasing incidences of infections associated with regular medical devices,need for faster healing, and overall reduced cost of treatment andaccelerated approval process of the drug-device combination products.
(Due to the length of the URL in the above paragraph, it may be necessaryto copy and paste this hyperlink into your Internet browser's URL addressfield. Remove the space if one exists.)
The drug eluting stents (DES) market is the largest segment and isexpected to reach US$8.47 billion by 2014 at a CAGR of 9.3%. Theantimicrobial catheter market is estimated to grow to a size of US$1.23billion in 2014 which presents the highest growth potential with an expectedgrowth rate of 23.4% in 2014. The cardiovascular treatment market isestimated to record revenues of US$9.59 billion in 2014 on account of thefact that cardiovascular diseases are one of the primary causes of deathglobally.
The European market is the largest geographical segment; and is expectedto be worth US$7.25 billion by 2014. Its 11.2% CAGR for 2009 to 2014 isdriven by the growing ageing population and the improvements in medicalscience and biotechnology that enables new product development. The secondlargest segment is the U.S. with a CAGR of 8.7% for 2009 to 2014. It isexpected to reach US$5.73 billion by 2014.
The report is titled 'Drug-Device Combination Market (2009-2014) and waspublished in July 2009.
Scope of the Report
This report aims to identify the specific segments that offer the highestgrowth potential in the near future; compares the products in respect to therelative entry barriers and expected new product developments in thosesegments. The report discusses the segmentation of the global drug-devicecombination as follows:
1. Drug device combination - products
Antimicrobial catheter, advanced wound care products, bone graftsubstitutes, antibiotic bone cements, drug eluting stents, photodynamictherapy, closed loop glucose monitor and insulin pump, steroid elutingelectrodes and others.
2. Drug device combination - application
Bone treatment, cancer treatment, diabetes treatment, skin caretreatment, antimicrobial applications, urological treatment, noncardiovascular treatment, cardiovascular treatment, ophthalmic treatment,others.
3. Drug device combination - technology
Bone graft substitutes- synthetic bone graft substitutes, demineralisedbone matrix and bone morphogenic proteins.
Contact our representative to sponsor this report
About MarketsandMarkets
MarketsandMarkets is a research and consulting firm that publishes 120market research (http://www.marketsandmarkets.com) reports per year. Eachstrategically analyzed report contains 250 pages of valuable market data,including more than 100 market data Summary tables and in-depth, five-levelsegmentation for each of the products, services, applications, technologies,ingredients and stakeholders categories. Our reports also analyze about 200patents, over 50 companies and micro markets that are mutually exclusive andcollectively exhaustive. Browse all our 120 titles athttp://www.marketsandmarkets.com.Contact: Ms. Sunita 108, West 13th Street, Wilmington DE, 19801 County of New Castle Tel: +1-888-989-8004 Email: [email protected]
SOURCE MarketsandMarkets
